期刊文献+

HSV-1 SM44株糖蛋白D基因真核表达载体的构建及其免疫效果观察 被引量:4

Construction and its immunization effect of the eukaryotic expression vector bearing HSV-1 glycoprotein D gene
原文传递
导出
摘要 目的构建HSV 1型SM44株糖蛋白D(gD)基因的真核表达载体 ,并用此重组质粒直接免疫小鼠 ,探讨HSV 1gD基因作为基因疫苗的可能性。方法从HSV 1基因组中扩增 gD的全编码基因 ,克隆入载体 pUC19中 ,测序鉴定后转入真核表达载体 pcDNA3.1( +)。所得重组质粒pcDNA gD以电穿孔法转染CHO细胞 ,并以荧光染色法鉴定表达效果。用 pcDNA gD免疫小鼠 ,ELISA法检测基因免疫的应答效果。结果成功地构建了可在真核细胞中有效表达的HSV 1gD真核表达载体 ,用其直接免疫小鼠可引起较高水平的特异性抗体应答。结论 gD的真核表达载体有可能作为HSV 1的基因疫苗 ,为进一步研究基于 gD的表位生物学和表位疫苗奠定了基础。 Aim To construct eukaryotic expression vector bearing HSV-1 glycoprotein D(gD) gene and to evaluate the possibility of designing HSV-1 gene vaccine with HSV gD gene. Methods The HSV 1 gD gene was amplified from the HSV 1 genome DNA and cloned into eukaryotic vector pcDNA3.1(+). The recombinant vector pcDNA gD was transfected into CHO cells by electroperforance method. Fluorescent staining and ELISA were used to test the expression of gD in CHO cells and response of mice to pcDNA gD. Results The eukaryotic expression vector containing HSV 1 gD gene was successfully constructed .The recombinant vector could induce higher specific immunoreaction in the immunized mice. Conclusion The recombinant vector pcDNA gD is valuable to designing HSV gene vaccine and studying epitope biology and epitope vaccine of HSV 1.
出处 《细胞与分子免疫学杂志》 CSCD 2000年第4期308-310,共3页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金资助 !No.39770040
关键词 HSV-1 糖蛋白D 真核表达 基因免疫 载体构建 herpes simplex virus 1 glycoprotein D eu karyotic expression gene immunization
  • 相关文献

参考文献2

共引文献2

同被引文献15

  • 1王战勇,王志玉,温红玲,宋艳艳,王桂亭,许洪芝.单纯疱疹病毒I型糖蛋白D酵母表达载体的构建[J].山东大学学报(医学版),2003,41(6):611-614. 被引量:3
  • 2萨姆布鲁克 EF弗里奇 等.分子克隆实验指南,第2版[M].北京:科学出版社,1992.34-57.
  • 3吴瑞萍 胡亚美 江载芳.诸福棠实用儿科学上册[M]:第6版[M].北京:人民卫生出版社,1996.735.
  • 4Ghiasi H, Bahri S, Nesburn AB, et al. Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus 1glycoproteins. Invest Ophthalmol Vis Sci, 1995, 36 (7):1 352-60.
  • 5Scherba G, Jin L, Schnitzlein WM, et al. Differential polymerase chain reaction for defection of wild-type and a vaccine strain of Aujeszky's desease (pseudorabies) virus. J Virol Methods, 1992, 38 (1): 131-43.
  • 6Nicola AV, Willis SH, Naidoo NN, et al. Structure-function analysis of soluble forms of herpes simplex virus glycoprotein D. J Virol, 1996, 70 (6): 3 815-22.
  • 7Whitbeck JC, Muggeridge MI, Rux AH, et al. The major neutralizing antigenic site on herpes simplex virus glycoprotein D overlaps a receptor-binding domain. J Virol, 1999,73 (12): 9879-90.
  • 8Tom A.Stavropoulos,Craig A.Strathdee.An Enhanced Packaging System for Helper-Dependent Herpes Simplex Virus Vectors[J].JOURNAL OF VIROLOGY,1998,72(9):7137.
  • 9Susan Zabierowski,Neal A.Deluca.Differential Cellular Requirements For Activation Of Herpes Simplex Virus Type 1 Early (Tk) And Late (Gc)Promoters By Icp4[J].Joumal Of Virology,2004,78(12):6162.
  • 10William P.Halford,Clinton D.Icp0,Icp4,Or Vp16 Expressed From Adenovirus Vectors Induces Reactivation Of Latent Herpes Simplex Virus Type 1 In Primary Cultures Of Latently Infected Trigeminal Ganglion Cells[J].Joumal of Virology,2001,75(13):6143.

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部